ESS Projects Growth Despite Q2 Shipping Hurdlesby Mark Eisenberg 19.08.2024ESS anticipates growth following Q2 shipping delays, plans August Energy Centers launch and funding expansion.
Caledonia Mining Sees Strong Q2 with Rising Gold Outputby Mark Eisenberg 18.08.2024Caledonia Mining boosts Q2 profits with increased gold production and promising project assessments, setting a strong growth path.
Artivion’s Q2 Growth and Future Outlookby Mark Eisenberg 18.08.2024Artivion reports 10% revenue growth, raises 2024 guidance. Key products and market expansion drive success.
Adaptimmune Launches Tecelra Amid Strong Q2 Resultsby Mark Eisenberg 18.08.2024Adaptimmune's Tecelra launch marks progress in cell therapy, with strong Q2 financials and strategic plans for cancer treatment.
Genmab Reports 36% Revenue Growth in H1 2024by Mark Eisenberg 15.08.2024Genmab's H1 2024 results show 36% revenue growth; DARZALEX sales surge, and strategic acquisition of ProfoundBio boosts future potential.
iCAD’s Revenue Surges with AI and SaaS Focusby Mark Eisenberg 15.08.2024iCAD's Q2 revenue increased by 21% as the company shifts to a cloud-based SaaS model, aiming for enhanced profitability.
NET Power Makes Strides in Clean Energy Pushby Mark Eisenberg 15.08.2024NET Power progresses on clean power, aiming for $60/MWh. Project Permian on track, driving utility-scale technology.
Asensus Surgical Faces Merger Vote Amid Financial Strainby Mark Eisenberg 15.08.2024Asensus Surgical's Q2 report highlights revenue increase, net loss, and crucial merger vote with KARL STORZ.
Cipher Mining Shares Growth, HPC Plans in Q2 Updateby Mark Eisenberg 15.08.2024Cipher Mining reports capacity boost and HPC business plans amid Q2 financial challenges, outlining strategic growth initiatives.
SoftBank Steers Confidently Amid Market Unrestby Mark Eisenberg 15.08.2024SoftBank focuses on AI growth with stable finances despite decreased net asset value and market volatility.